Recall
FDAHealthAugust 27, 2025

Amerisource Health Services LLC — chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) bliste

⚠️ Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
August 27, 2025

Nationwide in the USA

What's affected?

Product
chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) blisterpacks, NDC: 60687-430-01, (Individual Dose NDC: 60687-430-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.
Lot code
a)1020919

Additional details

Lot: a)1020919, 1021133, Exp 09/30/2026; 1021447, Exp 10/31/2026; 1021741, 1022202, Exp 11/30/2026; 1022474, Exp 12/31/2026 Lot: b) 1020460, exp 08/31/2026; 1022417, exp 12/31/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 2,708 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.